Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease

Author： Takeichi Naoya Yanagisawa Satoshi Kaneyama Tomoki Yagita Hideo Jin Young-Hee Kim Byung S. Koh Chang-Sung

ISSN： 1460-2377

Source： International Immunology, Vol.22, Iss.9, 2010-09, pp. : 729-738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Innate immune response induced by Theiler's murine encephalomyelitis virus infection

By Kim Byung Palma JoAnn Kwon Daeho Fuller Alyson

Immunologic Research, Vol. 31, Iss. 1, 2005-02 ,pp. : 1-12

Humana Press, Inc

Access to resources Recommend Favorite

Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T h 1 cells that is augmented by IL-4

By Tran G.T.

International Immunology, Vol. 13, Iss. 9, 2001-09 ,pp. : 1109-1120

Oxford University Press

Access to resources Recommend Favorite

A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity

By Watanabe M.

International Immunology, Vol. 12, Iss. 4, 2000-04 ,pp. : 555-562

Oxford University Press

Access to resources Recommend Favorite

Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease

By Miwa K.

International Immunology, Vol. 11, Iss. 6, 1999-06 ,pp. : 925-931

Oxford University Press

Access to resources Recommend Favorite

Characterization of murine CD70 by molecular cloning and mAb

By Yagita H.

International Immunology, Vol. 10, Iss. 4, 1998-04 ,pp. : 517-526

Oxford University Press

Access to resources Recommend Favorite